Posts Tagged Alcoholism
New research has demonstrated that the effects on white matter brain volume from long-term alcohol abuse are different for men and women.
Researchers from Boston University School of Medicine (BUSM) and Veterans Affairs (VA) Boston Healthcare System also suggest that when they stop drinking, women recover their white matter brain volume more quickly than men.
Previous research has linked alcoholism with white matter reduction, according to the researchers, who explain that white matter forms the connections between neurons, allowing communication between different areas of the brain.
In this latest study, a research team, led by Susan Mosher Ruiz, Ph.D., a postdoctoral research scientist in the Laboratory for Neuropsychology at BUSM and research scientist at the VA Boston Healthcare System, and Marlene Oscar Berman, Ph.D., professor of psychiatry, neurology and anatomy and neurobiology at BUSM and research career scientist at the VA Boston Healthcare System, employed structural magnetic resonance imaging (MRI) to determine the effects of drinking history and gender on white matter volume.
They examined brain images from 42 abstinent alcoholic men and women who drank heavily for more than five years and 42 nonalcoholic men and women. The researchers found that a greater number of years of alcohol abuse was associated with smaller white matter volumes in the alcoholic men and women. In the men, the decrease was observed in the corpus callosum, while in women this effect was observed in cortical white matter regions.
“We believe that many of the cognitive and emotional deficits observed in people with chronic alcoholism, including memory problems and flat affect, are related to disconnections that result from a loss of white matter,” said Mosher Ruiz.
The researchers also found that the number of daily drinks had a strong impact on alcoholic women, with the volume loss 1.5 to 2 percent for each additional drink. Additionally, there was an 8 to 10 percent increase in the size of the brain ventricles, which are areas filled with cerebrospinal fluid (CSF) that play a protective role in the brain. When white matter dies, CSF produced in the ventricles fills the ventricular space.
The researchers also found that in men, white matter brain volume in the corpus callosum recovered at a rate of 1 percent per year for each year of abstinence. For people who abstained less than a year, the researchers found evidence of increased white matter volume and decreased ventricular volume in women, but not in men. However, for people in recovery for more than a year, those signs of recovery disappeared in women and became apparent in men.
“These findings preliminarily suggest that restoration and recovery of the brain’s white matter among alcoholics occurs later in abstinence for men than for women,” said Mosher Ruiz. “We hope that additional research in this area can help lead to improved treatment methods that include educating both alcoholic men and women about the harmful effects of excessive drinking and the potential for recovery with sustained abstinence.”
The research was published online in Alcoholism: Clinical and Experimental Research.
Source: Boston University Medical Center
Among individuals with psychosis who are also heavy marijuana users, the age they first used marijuana is strongly linked to the age of their first bout of psychosis, according to a study of 57 patients.
Although marijuana use by itself is neither sufficient nor needed to trigger schizophrenia, “if cannabis use precipitates the onset of psychosis, efforts should be focused on designing interventions to discourage cannabis use in vulnerable individuals,” Dr. Juan A. Galvez-Buccollini and his associates said.
This caution pertains to someone with a first-degree relative with psychosis, which is “the highest risk factor for schizophrenia,” said Dr. Lynn E. Delisi, senior investigator for the study, a psychiatrist at the Boston VA Medical Center in Brockton, Mass., and professor of psychiatry at Harvard Medical School, Boston.
If someone had a first-degree relative, “I would caution them about the consequences of cannabis use and the association with schizophrenia,” she said.
Findings from previous research has shown that marijuana use is associated with an earlier age of psychosis onset in people abusing multiple substances, but studies have not looked at a possible link between the onset of cannabis use itself and resulting psychosis.
Because of this, Dr. Galvez-Buccollini, a psychiatry researcher at VA Boston Healthcare System and Harvard, and his colleagues interviewed 57 patients with a current diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or psychosis not otherwise specified, who also had a history of heavy cannabis use before the onset of psychosis. They defined heavy cannabis use as 50 or more uses during a one year period.
Average age of the subjects was 25 years with a range of 18-39 years. Of the total, 83 percent were men, and 88 percent were not married. The average age of psychosis onset was 22 years, and the average age for first psychosis-related hospitalization was 23.
Schizophrenia was the most common psychosis (42 percent), followed by schizoaffective disorder (32 percent). The average age of first marijuana use was 15, preceding psychosis onset by an average of 7 years.
During the study period, the prevalence of daily cannabis was 59 percent with another 30 percent reporting use 2-5 days per week, and the remaining 11 percent reporting weekly use. Alcohol abuse was 16 percent and alcohol dependence was 8 percent.
The researchers found a statistically significant link between the age when cannabis use first started and the age when psychosis was first diagnosed. This association was consistent after researchers excluded patients with any diagnosis of alcohol abuse or dependency during their lifetime.
The analysis also showed a strong link between the time a patient first smoked marijuana and their age of first psychosis hospitalization.
Marijuana affects dopamine receptors and can have other neurochemical effects.
“There are two components of cannabis, one that potentiates and another that antagonizes psychotic symptoms,” said Delisi. The balance between these two effects can differ among various strains of cannabis, she added.
Source: Schizophrenia Research